Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PINC: PCV10/PCV13 Mixed Schedule in Infants
NCT02918708Phase 4Withdrawn
- Sponsor
- UK Health Security Agency
- Primary completion
- Jan 2017
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection (2 arms), sponsored by UK Health Security Agency. Primary endpoint: Proportion of subjects with protective pneumococcal antibody levels. Status: withdrawn.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT02918708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02918708.